US Stock MarketDetailed Quotes

LBPS 4D pharma

Watchlist
  • 1.650
  • 0.0000.00%
Trading Oct 11 09:30 ET
37.19MMarket Cap-1.25P/E (TTM)

About 4D pharma Company

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

Company Profile

SymbolLBPS
Company Name4D pharma
CEOMr. Duncan Joseph Peyton
MarketNASDAQ
Employees88
Securities TypeDR
ADS Ratio1.0 : 8.0

Company Executives

  • Name
  • Position
  • Salary
  • Duncan Joseph Peyton
  • Executive Director,Chief Executive Officer
  • --
  • Dr. Alexander James Stevenson
  • Executive Director,Chief Scientific Officer
  • --
  • John Doyle
  • Chief Financial Officer
  • --
  • Professor Axel Gaston Glasmacher
  • Non-Executive Director,Chairman
  • --
  • Dr. Alexander Donald Macrae
  • Non-Executive Director
  • --
  • Dr. Edgardo Baracchini,PhD
  • Non-Executive Director
  • --
  • Paul Victor Maier
  • Non-Executive Director
  • --
  • Dr. Katrin Juliane Rupalla, PhD
  • Non-Executive Director
  • --
  • Laurence Dale
  • Company Secretary
  • --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.